
1
64000-00137 Rev 1
3
Instructions for Use for gammaCore Sapphire
TM
CV
4
(non-invasive vagus nerve stimulator) authorized for emergency use in the acute treatment of
5
adult patients with known or suspected COVID-19 who are experiencing exacerbation of
6
asthma-related dyspnea and reduced airflow, and for whom approved drug therapies are not
7
tolerated or provide insufficient symptom relief as assessed by their healthcare provider, using
8
non-invasive VNS on either side
of the patient’s neck during the COVID-19 pandemic.
9
10
11
12
4. COMMON SIDE EFFECTS ASSOCIATED WITH GAMMACORE SAPPHI
13
5
. WILL I STILL NEED TO TAKE MEDICATIONS…………………………….……………………………………………..….....5
14
………………………………………………………………………………………………..6
15
7. POTENTIAL RISKS AND COMPLICATIONS ASSOCIATED WITH OTHER VAGUS NERVE STIMULATION
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
21. ADDITIONAL WARNINGS AND PRECAUTIONS
…………………………………………………………………………..…25
31
32
33
34
35
36
Caution: Rx Only. US Federal Law restricts this device to sale by or on the order of a licensed healthcare provider.
37
38